NYSE · traded in Congress
Emerson Electric Company EMR
$160.8127 -1.5373 (-0.95%) Nov 9, 2026 4:02 AM ET
Market value$89.7B
P/E ratio-
Analyst target$181.50
52-week range-
Avg volume2,724,221
Dividend yield-
Chart
Analyst ratings
- 22 buy
- 9 hold
- 2 sell
Low target$140.00
Average target$186.79
High target$208.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $4,873M | - | $718M | 14.7% | |
| $4,562M | - | $618M | 13.6% | |
| $4,346M | - | $605M | 13.9% | |
| $4,855M | $2,520M | $637M | 13.1% |
New SEC filings
- S-3ASR S-3ASR filed Nov 9, 2026
- 10-K 10-K filed Nov 9, 2026
All EMR filings on SEC EDGAR ›
Congress trades in EMR
Members of Congress disclosed 4 transactions in EMR in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/17/2026 | Kevin Hern OK01 | Partial sale | $15,001 - $50,000 | 10/13/2026 filing |
| 09/14/2026 | Kevin Hern OK01 | Partial sale | $1,001 - $15,000 | 9/25/2026 filing |
| 09/14/2026 | Kevin Hern OK01 | Partial sale | $15,001 - $50,000 | 9/25/2026 filing |
| 07/30/2026 | Richard Dean Dr McCormick GA06 | Sale | $1,001 - $15,000 | 8/14/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
